Francesco Vendrame, MD, PhD

Dr Angela Zhu is a board-certified ophthalmologist at the Bascom Palmer Eye Institute with a double fellowship specialization in both pediatric and adult cornea, cataract, and external diseases. She is focused on caring for patients of all ages with a variety of ocular surface and anterior segment disorders using cutting-edge medical and surgical techniques. After receiving her bachelor's degrees in Chemistry and Biology from the Massachusetts Institute of Technology, Dr Zhu spent a dedicated research year at the Whitehead Institute of Biomedical Research investigating mammalian immune responses to bacterial infections.

Dr C Ola Landgren, is a board-certified hematologist/oncologist who specializes in multiple myeloma, smoldering myeloma, monoclonal gammopathy of undetermined significance, and related plasma cell disorders. His research approaches include detailed genomic characterization of tumor cells and cells in the bone marrow microenvironment, partnered with novel drug development, and advanced methods to rule out minimal residual disease (MRD). Dr Landgren has developed several novel strategies designed to identify MRD detection post-therapy.

Dr Gilberto Lopes is a medical oncologist and researcher who focuses on new anticancer drug development and global oncology. He has published more than 270 scientific papers and has led hundreds of clinical trials. Dr Lopes was the main investigator of Keynote 42, a clinical trial that demonstrated the efficacy of the immunotherapy drug pembrolizumab in people living with lung cancer. This groundbreaking study led to one of the FDA approvals of pembrolizumab. Additionally, Dr Lopes has contributed significantly to the development of several chemotherapies and targeted medications that address specific molecular changes in tumors.